We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Accrual Delayed in Adjuvant Bevacizumab Trial.
- Authors
Tuma, Rabiya S.
- Abstract
The article reports that the data safety monitoring board has stopped the medical trial of adjuvant bevacizumab and two chemotherapy regimens for early-stage colon cancer. This decision came after the board found an unexpected increase in the number of non-cancer-related deaths. According to several experts, the imbalance in deaths is a statistical anomaly. However, they agree that the safety committee has performed its job appropriately.
- Subjects
ADJUVANT treatment of cancer; CANCER chemotherapy; COLON cancer; CLINICAL trials; IMMUNOLOGICAL adjuvants
- Publication
JNCI: Journal of the National Cancer Institute, 2006, Vol 98, Issue 7, p439
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djj148